Page 8 - Stroke Council News Today

THURSDAY, Feb. 3, 2022 (HealthDay News) -- Nine in 10 Americans -- 91% -- live within an hour of lifesaving stroke care, researchers say.

Research Highlights: Researchers estimate that 91% of the U.S. population can reach an acute stroke ready hospital, primary stroke center or

THURSDAY, Feb. 3, 2022 (HealthDay News) -- Nine in 10 Americans -- 91% -- live within an hour of lifesaving stroke care, researchers say.

Statement Highlights: High blood pressure during pregnancy remains a major cause of maternal and fetal pregnancy-related complications and death, and

Two AHA new science advisories encourage clinicians to discuss healthy lifestyle practices with their patients at every visit and help them make changes to benefit heart health.

DALLAS, Nov. 2, 2021 — The American Heart Association has outlined 10 key features of a heart-healthy eating pattern in a new scientific statement

Statement Highlights: In a new statement on diet and heart health, the American Heart Association presents 10 key features of a heart-healthy eating

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. The temporary pause was due to reports of a serious condition called cerebral venous sinus thrombosis (CVST), which refers to blood clots in the brains veins - not in the arteries, as is the...

April 30, 2021 The American Heart Association/American Stroke Association (AHA/ASA) has released guidance to help physicians respond to, and understand, the reports of rare blood clots and low platelet counts after COVID-19 vaccination. The document, published online in Stroke, focuses on the diagnosis and management of cerebral venous sinus thrombosis (CVST) with vaccine-induced immune thrombotic thrombocytopenia (VITT), a condition that has been reported in people who have received the COVID...

 E-Mail DALLAS, April 29, 2021 – Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. The temporary pause was due to reports of a serious condition called cerebral venous sinus thrombosis (CVST), which refers to blood clots in the brain’s veins - not in the arteries, as is the case for most strokes - in combination with thrombocytopen...